Towards eliminating hepatitis C as a public health threat: different speeds, different needs.
作者信息
Matičič Mojca, Buti Maria
机构信息
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
出版信息
Euro Surveill. 2024 Jul;29(30). doi: 10.2807/1560-7917.ES.2024.29.30.2400462.
Abstract
摘要
相似文献
1
Towards eliminating hepatitis C as a public health threat: different speeds, different needs.迈向消除丙型肝炎这一公共卫生威胁：速度各异，需求不同。
Euro Surveill. 2024 Jul;29(30). doi: 10.2807/1560-7917.ES.2024.29.30.2400462.
2
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.在注射毒品人群中消除丙型肝炎：在卫生系统框架内采取行动的挑战和建议。
Liver Int. 2019 Jan;39(1):20-30. doi: 10.1111/liv.13949. Epub 2018 Sep 22.
3
A gender lens is needed in hepatitis C elimination research.丙型肝炎消除研究需要性别视角。
Int J Drug Policy. 2022 May;103:103654. doi: 10.1016/j.drugpo.2022.103654. Epub 2022 Mar 17.
4
Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.迈向欧盟及欧洲经济区国家消除乙型和丙型肝炎：监测世界卫生组织全球卫生部门战略核心指标并扩大关键干预措施
Euro Surveill. 2017 Mar 2;22(9). doi: 10.2807/1560-7917.ES.2017.22.9.30476.
5
Progress towards elimination goals for viral hepatitis.迈向消除病毒性肝炎目标的进展。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):533-542. doi: 10.1038/s41575-020-0332-6. Epub 2020 Jul 23.
6
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.丙型肝炎：欧洲及各国在欧洲消除丙型肝炎病毒成功战略的关键要素之初探
J Viral Hepat. 2018 Mar;25 Suppl 1:6-17. doi: 10.1111/jvh.12875.
7
Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies.迈向伊朗的丙型肝炎病毒消除之路：全面策略蓝图。
J Viral Hepat. 2024 Sep;31(9):565-572. doi: 10.1111/jvh.13975. Epub 2024 Jun 3.
8
The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.实现丙型肝炎消除需普及丙型肝炎疫苗。
BMC Med. 2019 Sep 18;17(1):175. doi: 10.1186/s12916-019-1411-9.
9
Elimination of Hepatitis C Virus in Australia: Laying the Foundation.澳大利亚消除丙型肝炎病毒：奠定基础。
Infect Dis Clin North Am. 2018 Jun;32(2):269-279. doi: 10.1016/j.idc.2018.02.006.
10
Can hepatitis C be eradicated in the United States?在美国丙型肝炎能被根除吗？
Antiviral Res. 2014 Oct;110:79-93. doi: 10.1016/j.antiviral.2014.07.015. Epub 2014 Aug 7.
引用本文的文献
1
The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis.丙型肝炎病毒依赖的对Nrf1/ARE介导的基因表达的抑制作用有利于病毒形态发生。
Viruses. 2025 Jul 28;17(8):1052. doi: 10.3390/v17081052.
本文引用的文献
1
Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Estonia, July to December 2022.2022 年 7 月至 12 月，在爱沙尼亚全国性调查中估算一般人群中慢性丙型肝炎感染的流行率。
Euro Surveill. 2024 Jul;29(30). doi: 10.2807/1560-7917.ES.2024.29.30.2300651.
2
Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Romania, 2020 to 2023.慢性丙型肝炎感染在普通人群中的流行率：来自罗马尼亚全国调查的结果，2020 年至 2023 年。
Euro Surveill. 2024 Jul;29(30). doi: 10.2807/1560-7917.ES.2024.29.30.2300663.
3
Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study.2017 年至 2023 年西班牙马德里减少吸毒人群丙型肝炎感染：一项回顾性研究。
Euro Surveill. 2024 Jul;29(29). doi: 10.2807/1560-7917.ES.2024.29.29.2300712.
4
A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022.一个利用监测系统为澳大利亚维多利亚州 2021 年 9 月至 2022 年 3 月期间被诊断患有丙型肝炎的患者提供临床护理的临床医生提供支持的试点项目。
Euro Surveill. 2024 Jul;29(29). doi: 10.2807/1560-7917.ES.2024.29.29.2400028.
5
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure.丙型肝炎相关肝细胞癌：即使丙型肝炎感染已治愈，仍是一个相关病因
Cancers (Basel). 2024 Apr 16;16(8):1521. doi: 10.3390/cancers16081521.
6
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.丙型肝炎感染的直接抗病毒疗法：全球注册、报销及限制情况
Lancet Gastroenterol Hepatol. 2024 Apr;9(4):366-382. doi: 10.1016/S2468-1253(23)00335-7. Epub 2024 Feb 15.
7
Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.2019年欧盟/欧洲经济区国家慢性丙型肝炎病毒感染的患病率：采用多参数证据综合分析
Lancet Reg Health Eur. 2023 Dec 13;36:100792. doi: 10.1016/j.lanepe.2023.100792. eCollection 2024 Jan.
8
A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.在收监监狱中实施一站式即时护理丙型肝炎 RNA 检测干预措施以提高治疗率：PIVOT 研究。
J Hepatol. 2023 Sep;79(3):635-644. doi: 10.1016/j.jhep.2023.04.019. Epub 2023 Apr 26.
9
Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination.荷兰丙型肝炎消除计划（CELINE）：全国性检索失访丙型肝炎患者如何有助于微消除。
Eur J Intern Med. 2022 Jul;101:93-97. doi: 10.1016/j.ejim.2022.04.024. Epub 2022 May 5.
10
Egypt's Ambitious Strategy to Eliminate Hepatitis C Virus: A Case Study.埃及消除丙型肝炎病毒的宏伟战略：案例研究。
Glob Health Sci Pract. 2021 Mar 31;9(1):187-200. doi: 10.9745/GHSP-D-20-00234.
Zotero 插件